⚠ Warning: Semaglutide/Tirzepatide are prescription medications. Not for patients with history of medullary thyroid carcinoma or MEN2. Requires medical consultation and ongoing physician monitoring.

Semaglutide and Tirzepatide Weight Loss Injections in Miami

Weight loss injections in Miami with semaglutide or tirzepatide, prescribed by Dr. Hernández Loy after a medical evaluation. Prescription required.

Physician-supervised weight loss injections in Miami. In-clinic protocols using Tirzepatide and Semaglutide with active physician monitoring and metabolic protection. In the SURMOUNT-1 clinical trial, tirzepatide produced up to 20.9% average body weight reduction at 72 weeks at the highest dose studied.

Source: SURMOUNT-1, N Engl J Med 2022 (PubMed). Results refer to FDA-approved tirzepatide in a controlled trial. Compounded medications are not FDA-approved and were not evaluated in this trial. Individual results vary.

Medications prescribed at Legacy MD may include FDA-approved brand-name products and compounded formulations prepared by a state-licensed pharmacy. Compounded medications are not FDA-approved and are not the same as brand-name drugs. Your physician will explain which option fits your medical needs. Prescription required; not right for everyone.

Overview

Clinical Overview

  • •GLP-1 receptor agonists (semaglutide, tirzepatide) enhance satiety signaling and slow gastric emptying
  • •FDA-approved for type 2 diabetes and chronic weight management in patients with obesity or overweight with comorbidities
  • •Support sustainable weight loss through better metabolic function and appetite regulation
  • •Originally developed for diabetes; now widely used for non-diabetic weight management
  • •Administered as weekly self-injections with gradual dosing titration over 4-6 months
  • •Response varies from person to person; your physician reviews it at each visit.
Candidacy

Ideal For

  • Type 2 diabetes patients with obesity or overweight status seeking dual weight loss and metabolic control
  • Individuals with weight loss resistance despite diet and exercise modification
  • Those seeking non-surgical approach to chronic weight management
  • Patients with cardiovascular risk factors seeking metabolic improvement
  • Motivated individuals committed to ongoing medical monitoring and lifestyle modification

Contraindications

  • Personal or family history of medullary thyroid cancer
  • Multiple Endocrine Neoplasia Type 2 (MEN2)
  • Type 1 diabetes
  • Severe kidney disease (eGFR <15)
  • Active pancreatitis or history of severe pancreatitis without identified trigger
  • Pregnancy or nursing mothers
  • Allergy to semaglutide, tirzepatide, or components
What to Expect

Downtime

None. Weekly self-administered injection. Immediate return to all activities.

Timeline

Response varies from person to person; your physician reviews it at each visit. Weight loss plateaus every 6-8 weeks (managed with dose adjustment).

Duration of Results

Ongoing; long-term therapy anticipated. Discontinuation typically results in appetite return and weight regain over 12-16 weeks.

Appointment Length

60-90 minutes for initial assessment; 30-45 minutes for follow-up visits

Safety

Common Side Effects

  • •Nausea (expected, usually transient 1-4 weeks)
  • •Reduced appetite (intentional mechanism)
  • •Constipation or diarrhea
  • •Abdominal discomfort
  • •Fatigue
  • •Vomiting (less common than nausea)

Rare Risks

  • ⚠Dehydration (managed with fluid intake)
  • ⚠Acute kidney injury (especially if baseline kidney disease)
  • ⚠Gallstones
  • ⚠Pancreatitis (rare)
  • ⚠Thyroid-related concerns (theoretical; extensive safety data reassuring)
  • ⚠Severe hypoglycemia if on concurrent insulin (managed with medication adjustment)
FAQs
Will I regain weight if I stop taking GLP-1 medication?

Most patients regain some weight after discontinuation as appetite signals reactivate, typically over 12-16 weeks. Maintaining results depends on continued lifestyle changes and follow-up with your physician. Results vary. The goal is using medication as a metabolic reset tool while establishing long-term behavioral change through dietary improvements and exercise.

Is GLP-1 safe long-term? What about the boxed warning about thyroid cancer?

Your physician reviews the risks and the boxed warning about thyroid tumors before prescribing and monitors you during treatment. GLP-1 medications are not for everyone.

Can I take GLP-1 if I also have high blood pressure or take blood sugar medications?

Yes, but it requires careful monitoring. If you're on insulin or sulfonylureas, adding GLP-1 can cause low blood sugar, so we reduce those medications. If you're on blood pressure medications, weight loss may lower blood pressure, requiring adjustment. Regular follow-ups and bloodwork allow us to adjust your medications as your weight and metabolism improve.

How quickly will I see weight loss results?

Response varies from person to person; your physician reviews it at each visit. Weight loss plateaus every 6-8 weeks and are managed through dose adjustment and dietary review.

What lifestyle changes are needed while taking GLP-1?

Medication works best with proper nutrition and exercise. Dietary modifications include smaller portions, lower fat intake, and protein emphasis to prevent gastrointestinal upset. Exercise prescription typically targets 150+ minutes per week of moderate activity. Behavioral support and accountability are essential components of the protocol.

Who is a candidate for GLP-1 weight loss therapy?

Adults who want medically supervised weight loss and pass a physician evaluation may be candidates. Your doctor reviews your history, medications and labs when indicated, and GLP-1 therapy is not right for everyone, including people with a personal or family history of medullary thyroid carcinoma or MEN2.

How long does GLP-1 weight loss treatment last?

Treatment length is set by your physician after an evaluation and depends on your medical needs and how you respond. Follow-up visits continue for monitoring while you are on therapy.

What happens at the first GLP-1 evaluation in Miami?

You meet Dr. Hernandez Loy for a medical history review, an exam and a discussion of your goals and options. The evaluation decides whether GLP-1 therapy fits your medical needs.

What happens at the first evaluation

You meet Dr. Hernandez Loy for a medical history review, an exam and a discussion of your goals and options. The evaluation decides whether GLP-1 therapy fits your medical needs.

Some patients call these treatments weight loss shots; the first visit is the same.

Serving Miami, Kendall and Coral Gables

Legacy MD offers physician-supervised GLP-1 weight loss care from one clinic in Miami and welcomes patients from Kendall and Coral Gables. Book online or call the office.

Legacy MD Anti-Aging Medicine, 4960 SW 72nd Ave, Ste 203, Miami, FL 33155. Phone: (305) 456-8984.

Ready to Learn More?

Schedule a comprehensive metabolic assessment with Dr. Hernández Loy.

Schedule Your Assessment